Lungteh Shipbuilding Co., LTD
- Investment Period: July, 2019 ~ June, 2022
- Investment Amount: NT$ 42,429 K
- Realized Proceeds: NT$ 154,509 K
The company's main business is the production of medium and high-speed boats. Its uses include offshore patrol boats, inshore patrol boats, personnel operation and maintenance ships, high-speed passenger ships, research and survey ships, fire-fighting and rescue ships, port operation ships, and unmanned aerial vehicles. Boats, etc., and also provides repair services for ex-ships.
Tigerair Taiwan
- Investment Period: Nov, 2020 ~ March, 2021
- Investment Amount: $NT 30,000 K
- Realized Proceeds: $NT 41,760 K
Tigerair Taiwan officially launched on September 26th, 2014. It is an investment subsidiary of China Airlines Group, which also Taiwan's first and only low-cost airline in current. It will apply for listing at the end of December 2021. It hopes to assist Tigerair Taiwan through the listing capital increase plan. In the future, the aviation network will be deeply cultivated and expanded to achieve the goal of sustainable operation.
Drewloong Precision, INC.
- Investment Period: July 17th, 2019 ~ June 4th, 2020
- Investment Amount: $NT 65,676 K
- Realized Proceeds: $NT 97,281 K
Mainly engaged in the research, development, production and sales of large aircraft fuselage structural components, large aircraft engine structural components and special molds and jigs. In the international aerospace industry supply chain system, the company is a full-energy manufacturer of aircraft structures, has complete special process technology capabilities, and has certifications from major leading companies such as Boeing and Safran.
Locus Cell
- Investment Period: April 27th, 2021 ~ April 1th, 2022
- Investment Amount: $NT 50,000 K
- Realized Proceeds: $NT 99,700 K
Locus Cell is led by Hong-Nerng Ho, the former president of National Taiwan University Hospital, and cooperates with Dr. Kazuchika Furuishi, the former CEO of Japan's Hitachi Group and Minaris, the world's largest cell therapy CDMO in terms of market share, to introduce advanced foreign cell therapy products and technical resources, and Taiwan’s medical clinical resources to jointly create Asian’s largest cell therapy factory.
Enrestec
- Investment Period: July 17th, 2019 ~ June 4th, 2020
- Investment Amount: $NT 65676 K
- Realized Proceeds: $NT 97,281 K
Enrestec uses its original thermal cracking technology to effectively regenerate waste rubber products and resources into raw materials needed for the industry. At the same time, it provides innovative technologies for the rubber industry chain and fully utilizes low-carbon recycled raw materials in accordance with the circular economy production model to achieve low-carbon production. The goal is to reduce Taiwan’s demand for energy resources.
STARLUX Airlines
- Investment Period: Aug. 2022 ~ Feb. 2025
- Investment Amount: $NT 106,153 K
- Realized Proceeds: $NT 192,674 K
STARLUX Airlines, founded on May 2, 2018, is Taiwan’s third major international airline alongside China Airlines and EVA Air. The company is positioned as a premium carrier, dedicated to delivering safe, comfortable, and world-class travel experiences through exceptional service and modern hospitality. With a growing network across Asia, North America and Europe, STARLUX continues to expand its global presence. The airline was officially listed on the Taiwan Stock Exchange on October 25, 2024.
XCONN
- Investment Period: Aug. 2024 ~ May. 2026
- Investment Amount: $NT 98,130 K
- Realized Proceeds: $NT 236,082 K
XConn is a leading provider of Compute Express Link (CXL) memory interconnect and memory-sharing technologies, serving key markets including AI and HPC. The company is recognized as the industry's only supplier with commercially available CXL chip solutions. In January 2026, Marvell Technology announced the acquisition of XConn, making it a wholly owned subsidiary and further strengthening its position in next-generation data center infrastructure.
